SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-17-006778
Filing Date
2017-02-14
Accepted
2017-02-14 12:17:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SANDS CAPITAL MANAGEMENT, LLC SC 13GA NO. 2 12-31-2016 (BIOMARIN PHARMACEUTICAL bmrn0217.txt SC 13G/A 9323
  Complete submission text file 0001140361-17-006778.txt   11175
Mailing Address SANDS CAPITAL MANAGEMENT, LLC 1000 WILSON BLVD, SUITE 3000 ARLINGTON VA 22209
Business Address SANDS CAPITAL MANAGEMENT, LLC 1000 WILSON BLVD, SUITE 3000 ARLINGTON VA 22209 703-562-4000
SANDS CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001020066 (see all company filings)

IRS No.: 202830751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Subject) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-56595 | Film No.: 17605681
SIC: 2834 Pharmaceutical Preparations